Skip to main content
Top
Published in: Clinical Rheumatology 7/2023

06-03-2023 | Rheumatoid Arthritis | BRIEF REPORT

Barriers and facilitators for physical activity in rheumatic and musculoskeletal disease: a European-based survey

Authors: George S. Metsios, S. A. M. Fenton, K. Tzika, R. H. Moe, G. E. Fragoulis, T. P. M. Vliet Vlieland, E. Nikiphorou, C. H. M. Van den Ende, I. Fatouros, M. van der Esch, K. Niedermann, A. Stavropoulos-Kalinoglou, J. J. C. S. Veldhuijzen van Zanten, N. Brodin, C. M. O’Brien, Y. Koutedakis, N. Kennedy, T. W. Swinnen, C. Bostrom, G. D. Kitas, The IMPACT-RMD Consortium

Published in: Clinical Rheumatology | Issue 7/2023

Login to get access

Abstract

Physical activity (PA) is a key strategy for improving symptoms in people with rheumatic and musculoskeletal diseases (RMDs). The aim of this study was to investigate and rank the importance of known barriers and facilitators for engaging in PA, from the perspective of people living with RMD. Five hundred thirty-three people with RMD responded to a survey (nine questions) disseminated by the People with Arthritis and Rheumatism (PARE) network of the European Alliance of Associations for Rheumatology (EULAR). The survey required participants to rank — based on their perceived importance — known PA barriers and facilitators from the literature, and specifically RMD symptoms as well as healthcare and community factors that may affect PA participation. Of the participants, 58% reported rheumatoid arthritis as their primary diagnosis, 89% were female, and 59% were between 51 and 70 years of age. Overall, participants reported fatigue (61.4%), pain (53.6%) and painful/swollen joints (50.6%) as the highest ranked barriers for engaging in PA. Conversely, less fatigue (66.8%) and pain (63.6%), and being able to do daily activities more easy (56.3%) were identified as the most important facilitators to PA. Three literature identified PA barriers, i.e., general health (78.8%), fitness (75.3%) and mental health (68.1%), were also ranked as being the most important for PA engagement. Symptoms of RMDs, such as pain and fatigue, seem to be considered the predominant barriers to PA by people with RMD; the same barriers are also the ones that they want to improve through increasing PA, suggesting a bi-directional relationship between these factors.
Key Points
Symptoms of rheumatic and musculoskeletal disease (RMD) are the predominant barriers for lack of physical activity engagement.
RMD symptoms are the factors that people with RMDs want to improve when engaging in PA.
The barriers that stop people living with RMDs to do more PA are the ones that can be significantly improved through PA engagement.
Literature
1.
go back to reference Metsios GS, Moe RH, Kitas GD (2020) Exercise and inflammation. Best Pract Res Clin Rheumatol 34(2):101504CrossRefPubMed Metsios GS, Moe RH, Kitas GD (2020) Exercise and inflammation. Best Pract Res Clin Rheumatol 34(2):101504CrossRefPubMed
2.
3.
go back to reference Rausch Osthoff AK, Niedermann K, Braun J, Adams J, Brodin N, Dagfinrud H et al (2018) 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis 77:1251–1260 Rausch Osthoff AK, Niedermann K, Braun J, Adams J, Brodin N, Dagfinrud H et al (2018) 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis 77:1251–1260
4.
go back to reference Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76(1):17–28CrossRefPubMed Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76(1):17–28CrossRefPubMed
5.
go back to reference Veldhuijzen van Zanten JJ, Rouse PC, Hale ED, Ntoumanis N, Metsios GS, Duda JL et al (2015) Perceived barriers, facilitators and benefits for regular physical activity and exercise in patients with rheumatoid arthritis: a review of the literature. Sports Med 45(10):1401–12CrossRefPubMedPubMedCentral Veldhuijzen van Zanten JJ, Rouse PC, Hale ED, Ntoumanis N, Metsios GS, Duda JL et al (2015) Perceived barriers, facilitators and benefits for regular physical activity and exercise in patients with rheumatoid arthritis: a review of the literature. Sports Med 45(10):1401–12CrossRefPubMedPubMedCentral
6.
go back to reference Niedermann K, Nast I, Ciurea A, Vliet Vlieland T, van Bodegom-Vos L (2019) Barriers and facilitators of vigorous cardiorespiratory training in axial spondyloarthritis: surveys among patients, physiotherapists, and rheumatologists. Arthritis Care Res (Hoboken) 71(6):839–851CrossRefPubMed Niedermann K, Nast I, Ciurea A, Vliet Vlieland T, van Bodegom-Vos L (2019) Barriers and facilitators of vigorous cardiorespiratory training in axial spondyloarthritis: surveys among patients, physiotherapists, and rheumatologists. Arthritis Care Res (Hoboken) 71(6):839–851CrossRefPubMed
7.
go back to reference Harb S, Pelaez S, Carrier ME, Kwakkenbos L, Bartlett SJ, Hudson M, et al (2021) Barriers and facilitators to physical activity for people with scleroderma: a scleroderma patient-centered intervention network cohort study. Arthritis Care Res (Hoboken) Harb S, Pelaez S, Carrier ME, Kwakkenbos L, Bartlett SJ, Hudson M, et al (2021) Barriers and facilitators to physical activity for people with scleroderma: a scleroderma patient-centered intervention network cohort study. Arthritis Care Res (Hoboken)
8.
go back to reference Metsios GS, Koutedakis Y, Veldhuijzen van Zanten JJ, Stavropoulos-Kalinoglou A, Vitalis P, Duda JL et al (2015) Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study. Rheumatology (Oxford) 54(12):2215–20PubMed Metsios GS, Koutedakis Y, Veldhuijzen van Zanten JJ, Stavropoulos-Kalinoglou A, Vitalis P, Duda JL et al (2015) Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study. Rheumatology (Oxford) 54(12):2215–20PubMed
9.
go back to reference Sobejana M, van den Hoek J, Metsios GS, Kitas GD, Jorstad HT, van der Leeden M et al (2021) Cardiorespiratory fitness and physical activity in people who have rheumatoid arthritis at an increased risk of cardiovascular disease: a cross-sectional study. Rheumatol Int 41(12):2177–2183CrossRefPubMed Sobejana M, van den Hoek J, Metsios GS, Kitas GD, Jorstad HT, van der Leeden M et al (2021) Cardiorespiratory fitness and physical activity in people who have rheumatoid arthritis at an increased risk of cardiovascular disease: a cross-sectional study. Rheumatol Int 41(12):2177–2183CrossRefPubMed
10.
go back to reference Metsios GS, Fenton SAM, Moe HR, van der Esch M, Veldhuijzen van Zanten JJCS, Koutedakis Y et al (2019) Implementation of physical activity into routine clinical practice in rheumatic musculoskeletal disease: the IMPACT-RMD study protocol and rationale. Mediterr J Rheumatol 30(4):231–6CrossRefPubMedPubMedCentral Metsios GS, Fenton SAM, Moe HR, van der Esch M, Veldhuijzen van Zanten JJCS, Koutedakis Y et al (2019) Implementation of physical activity into routine clinical practice in rheumatic musculoskeletal disease: the IMPACT-RMD study protocol and rationale. Mediterr J Rheumatol 30(4):231–6CrossRefPubMedPubMedCentral
11.
go back to reference Hurkmans E, Giesenvander FJ, Vliet Vlieland TP, Schoones J, Van den Ende EC (2009) Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database Syst Rev 2009(4):CD006853 PubMedPubMedCentral Hurkmans E, Giesenvander FJ, Vliet Vlieland TP, Schoones J, Van den Ende EC (2009) Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database Syst Rev 2009(4):CD006853 PubMedPubMedCentral
12.
go back to reference Rongen-van Dartel SA, Repping-Wuts H, Flendrie M, Bleijenberg G, Metsios GS, van den Hout WB et al (2015) Effect of aerobic exercise training on fatigue in rheumatoid arthritis: a meta-analysis. Arthritis Care Res (Hoboken) 67(8):1054–1062CrossRefPubMed Rongen-van Dartel SA, Repping-Wuts H, Flendrie M, Bleijenberg G, Metsios GS, van den Hout WB et al (2015) Effect of aerobic exercise training on fatigue in rheumatoid arthritis: a meta-analysis. Arthritis Care Res (Hoboken) 67(8):1054–1062CrossRefPubMed
13.
go back to reference O’Brien CM, Ntoumanis N, Duda JL, Kitas GD, Veldhuijzen van Zanten J, Metsios GS et al (2021) Pain and fatigue are longitudinally and bi-directionally associated with more sedentary time and less standing time in rheumatoid arthritis. Rheumatology (Oxford) 60(10):4548–57CrossRefPubMed O’Brien CM, Ntoumanis N, Duda JL, Kitas GD, Veldhuijzen van Zanten J, Metsios GS et al (2021) Pain and fatigue are longitudinally and bi-directionally associated with more sedentary time and less standing time in rheumatoid arthritis. Rheumatology (Oxford) 60(10):4548–57CrossRefPubMed
14.
go back to reference Metsios GS, Kitas GD (2020) Should patients with rheumatic diseases take pain medication in order to engage in exercise? Expert Rev Clin Immunol 16(3):235–237CrossRefPubMed Metsios GS, Kitas GD (2020) Should patients with rheumatic diseases take pain medication in order to engage in exercise? Expert Rev Clin Immunol 16(3):235–237CrossRefPubMed
15.
go back to reference Davergne T, Tekaya R, Sellam J, Tournadre A, Mitrovic S, Ruyssen-Witrand A et al (2021) Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients. BMC Musculoskelet Disord 22(1):915CrossRefPubMedPubMedCentral Davergne T, Tekaya R, Sellam J, Tournadre A, Mitrovic S, Ruyssen-Witrand A et al (2021) Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients. BMC Musculoskelet Disord 22(1):915CrossRefPubMedPubMedCentral
Metadata
Title
Barriers and facilitators for physical activity in rheumatic and musculoskeletal disease: a European-based survey
Authors
George S. Metsios
S. A. M. Fenton
K. Tzika
R. H. Moe
G. E. Fragoulis
T. P. M. Vliet Vlieland
E. Nikiphorou
C. H. M. Van den Ende
I. Fatouros
M. van der Esch
K. Niedermann
A. Stavropoulos-Kalinoglou
J. J. C. S. Veldhuijzen van Zanten
N. Brodin
C. M. O’Brien
Y. Koutedakis
N. Kennedy
T. W. Swinnen
C. Bostrom
G. D. Kitas
The IMPACT-RMD Consortium
Publication date
06-03-2023
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 7/2023
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-023-06518-7

Other articles of this Issue 7/2023

Clinical Rheumatology 7/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.